John Shu-Nan Chen
CIK 1876909 · View on SEC EDGAR ↗
First SEC filing: Jan. 26, 2022 · Latest: Jan. 26, 2022
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 23, 2023 | FGIWW | A | 48,449 | — | — | 48,449 Direct | — | Acquired | (price as of 2026-08-20) |
| March 30, 2022 | FGIWW | A | 23,375 | — | — | 23,375 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 24, 2022 | FGIWW | A | 26,750 | — | — | 26,750 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 23, 2023 | FGIWW | Employee Stock Option (right to buy) | Ordinary Shares (48,449) | $2.26 | May 11, 2032 | 48,449 | Acquired |
| March 30, 2022 | FGIWW | Stock Option (right to buy) | Common Stock (23,375) | $3.07 | March 30, 2032 | 23,375 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $205,969 | — | — | $187,200 | — | — | — | $610,369 |
| 2024 | $207,692 | — | — | $180,000 | — | — | $12,702 | $580,394 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.